- Home
- EBS vs ABSI Comparison
EBS vs ABSI Comparison
Compare EBS & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- ABSI
- Stock Information
- Founded
- EBS 1998
- ABSI 2011
- Country
- EBS United States
- ABSI United States
- Employees
- EBS N/A
- ABSI N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- EBS Health Care
- ABSI Health Care
- Exchange
- EBS Nasdaq
- ABSI Nasdaq
- Market Cap
- EBS 423.6M
- ABSI 505.4M
- IPO Year
- EBS 2006
- ABSI 2021
- Fundamental
- Price
- EBS $10.48
- ABSI $4.11
- Analyst Decision
- EBS Strong Buy
- ABSI Strong Buy
- Analyst Count
- EBS 2
- ABSI 6
- Target Price
- EBS $13.50
- ABSI $7.98
- AVG Volume (30 Days)
- EBS 1.4M
- ABSI 5.9M
- Earning Date
- EBS 10-29-2025
- ABSI 11-12-2025
- Dividend Yield
- EBS N/A
- ABSI N/A
- EPS Growth
- EBS N/A
- ABSI N/A
- EPS
- EBS 1.35
- ABSI N/A
- Revenue
- EBS $788,900,000.00
- ABSI $4,138,000.00
- Revenue This Year
- EBS N/A
- ABSI $40.12
- Revenue Next Year
- EBS $19.24
- ABSI $331.37
- P/E Ratio
- EBS $7.77
- ABSI N/A
- Revenue Growth
- EBS N/A
- ABSI 27.32
- 52 Week Low
- EBS $4.02
- ABSI $2.01
- 52 Week High
- EBS $13.41
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- EBS 54.80
- ABSI 52.49
- Support Level
- EBS $9.21
- ABSI $4.15
- Resistance Level
- EBS $13.41
- ABSI $4.38
- Average True Range (ATR)
- EBS 0.82
- ABSI 0.36
- MACD
- EBS 0.17
- ABSI -0.09
- Stochastic Oscillator
- EBS 32.84
- ABSI 13.53
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.